The article "Inhibition effects of acridone on the growth of breast cancer cells in vivo", by Y.-F. Xia, H.
View Article and Find Full Text PDFGlucocorticoid-induced tumor necrosis factor receptor (GITR) is a co-stimulatory receptor and an important target for cancer immunotherapy. We herein present a potent FcγR-independent GITR agonist IBI37G5 that can effectively activate effector T cells and synergize with anti-programmed death 1 (PD1) antibody to eradicate established tumors. IBI37G5 depends on both antibody bivalency and GITR homo-dimerization for efficient receptor cross-linking.
View Article and Find Full Text PDF